Omega-3 fatty acids (ῳ-3 fatty acids) in epilepsy: animal models and human clinical trials

References

• Martin K, Jackson CF, Levy RG, et al. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. 2016 Feb 9;2:CD001903.
   PubMedGoogle Scholar
• Friedman D, Devinsky O. Cannabinoids in epilepsy. N Engl J Med. 2015;373:1048–1058.
   PubMed Web of Science ®Google Scholar
• Riediger ND, Othman RA, Suh M, et al. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc. 2009;109:668–679.
   PubMed Web of Science ®Google Scholar
• Leaf A, Xiao YF, Kang JX, et al. Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J Membr Biol. 2005;206:129–139.
   PubMed Web of Science ®Google Scholar
• De Caterina R. n–3 Fatty acids in cardiovascular disease. N Engl J Med. 2011;364:2439–2450.
   PubMed Web of Science ®Google Scholar
• Kelley DS, Siegel D, Vemuri M, et al. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr. 2007;86:324–333.
   PubMed Web of Science ®Google Scholar
• GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial. Lancet. 1999;354:447–455.
   PubMed Web of Science ®Google Scholar
• Wen YT, Dai JH, Gao Q. Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2014;24:470–475.
   PubMed Web of Science ®Google Scholar
• Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308:1024–1033.
   PubMed Web of Science ®Google Scholar
• Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain ῳ-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003;111:e39–e44.
   PubMed Web of Science ®Google Scholar
• Makrides M, Gibson RA, McPhee AJ, et al. DOMInO Investigative Team, authors. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304:1675–1683.
   PubMed Web of Science ®Google Scholar
• Taha AY, Burnham WM, Auvin S. Polyunsaturated fatty acids and epilepsy. Epilepsia. 2010;51:1348–1358.
   PubMed Web of Science ®Google Scholar
• Calder P. Mechanisms of action of (n-3) fatty acids. J Nutr. 2012;142:592S–599S.
   PubMed Web of Science ®Google Scholar
• Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008;1237:35–43.
   PubMed Web of Science ®Google Scholar
• Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 2006;139:991–997.
   PubMed Web of Science ®Google Scholar
• Jernerén F, Elshorbagy AK, Oulhaj A, et al. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015;102:215–221.
   PubMed Web of Science ®Google Scholar
• Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304:1903–1911.
   PubMed Web of Science ®Google Scholar
• Witte AV, Kerti L, Hermannstädter HM, et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex. 2014;24:3059–3068.
   PubMed Web of Science ®Google Scholar
• Xiao YF, Kang J, Morgan J, et al. Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci. 1995;92:11000–11004.
   PubMed Web of Science ®Google Scholar
• Kang JX, Leaf A. Evidence that free polyunsaturated fatty acids modify Na_channels by directly binding to the channel proteins. Proc Natl Acad Sci. 1996;93:3542–3546.
   PubMed Web of Science ®Google Scholar
• Xiao YF, Gomez AM, Morgan JP, et al. Suppression of voltage gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci. 1997;94:4182–4187.
   PubMed Web of Science ®Google Scholar
• Leaf A, Kang J, Xiao Y, et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646–2652.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res. 1999;846:112–121.
   PubMed Web of Science ®Google Scholar
• Taha AY, Huot PS, Reza-Lopez S, et al. Seizure resistance in fat-1 transgenic mice endogenously synthesizing high levels of omega-3 polyunsaturated fatty acids. J Neurochem. 2008;105:380–388.
   PubMed Web of Science ®Google Scholar
• Willis S, Samala R, Rosenberger TA, et al. Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models. Epilepsia. 2009;50:138–142.
   PubMed Web of Science ®Google Scholar
• El-Mowafy AM, Abdel-Dayem MA, Abdel-Aziz A, et al. Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility. Biochim Biophys Acta. 2011;1811:460–467.
   PubMed Web of Science ®Google Scholar
• Abdel-Dayem MA, Elmarakby AA, Abdel-Aziz AA, et al. Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen. Drugs R D. 2014;14:85–94.
   PubMedGoogle Scholar
• Musto AE, Walker CP, Petasis NA, et al. Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1. PLoS One. 2015;10:e0116543.
   PubMed Web of Science ®Google Scholar
• Climax J, Sewell RD. Modification of convulsive behaviour and body temperature in mice by intracerebroventricular administration of prostaglandins, arachidonic acid and the soluble acetylsalicylic acid salt lysine acetylsalicylate. Arch Int Pharmacodyn Ther. 1981;250:254–265.
   PubMedGoogle Scholar
• Bandero CR, Salvadori MG, Gomes AT, et al. Fish-oil attenuates methylmalonate-induced seizures. Epilepsy Res. 2013;105:69–76.
   PubMed Web of Science ®Google Scholar
• Flores-Mancilla LE, Hernandez-Gonzalez M, Guevara MA, et al. Long-term fish-oil supplementation attenuates seizure activity in the amygdala induced by 3-mercaptopropionic acid in adult male rats. Epilepsy Behav. 2014;33:126–134.
   PubMed Web of Science ®Google Scholar
• Gilby KL, Jans J, McIntyre DC. Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale. Neuroscience. 2009;163:750–758.
   PubMed Web of Science ®Google Scholar
• Chen CC, Chaung HC, Chung MY, et al. Menhaden fish-oil improves spatial memory in rat pups following recurrent pentylenetetrazole-induced seizures. Epilepsy Behav. 2006;8:516–521.
   PubMed Web of Science ®Google Scholar
• Curatolo N, Lecointe C, Bordet R, et al. Oral administration of docosahexaenoic acid/eicosapentaeinoic acids is not anticonvulsant in rats: implications for translational research. Pediatr Res. 2011;70:584–588.
   PubMed Web of Science ®Google Scholar
• Taha AY, Trepanie37r MO, Ciobanu FA, et al. A minimum of 3 months of dietary fish-oil supplementation is required to raise amygdaloid afterdischarge seizure thresholds in rats–implications for treating complex partial seizures. Epilepsy Behav. 2013;27:49–58.
   PubMed Web of Science ®Google Scholar
• Voskuyl RA, Vreugdenhil M, Kang JX, et al. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol. 1998;341:145–152.
   PubMed Web of Science ®Google Scholar
• Taha AY, Jeffrey MA, Taha NM, et al. Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats. Epilepsy Behav. 2010;17:336–343.
   PubMed Web of Science ®Google Scholar
• Musto AE, Gjorstrup P, Bazan NG. The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia. 2011;52:1601–1608.
   PubMed Web of Science ®Google Scholar
• Trepanier MO, Taha AY, Mantha RL, et al. Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses. Epilepsy Res. 2012;99:225–232.
   PubMed Web of Science ®Google Scholar
• Scorza FA, Cavalheiro EA, Arida RM, et al. Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study. Epilepsy Behav. 2009;15:527–528.
   PubMed Web of Science ®Google Scholar
• Matthews H, Granger N, Wood J, et al. Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial. Vet J. 2012;191:396–398.
   PubMed Web of Science ®Google Scholar
• Pages N, Maurois P, Delplanque B, et al. Brain anticonvulsant protection of mice given chronic carbamazepine under various fatty acid and magnesium diet conditions. PLEFA. 2012;87:63–70.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab BA, Shaikh IA, Khateeb MM, et al. Omega 3 polyunsaturated fatty acids enhance the protective effect of levetiracetam against seizures, cognitive impairment and hippocampal oxidative DNA damage in young kindled rats. Pharmacol Biochem Behav. 2015;135:105–113.
   PubMed Web of Science ®Google Scholar
• DeGiorgio CM, Miller PR, Harper R, et al. Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomized placebo-controlled crossover study. J Neurol Neurosurg Psychiatry. 2015;86:65–70.
   PubMed Web of Science ®Google Scholar
• Chaddha A, Eagle K. Omega-3 fatty acids and heart health. Circulation. 2015;132:e350–e352.
   PubMed Web of Science ®Google Scholar
• Di Stasi D, Bernasconi R, Marchioli R, et al. Early modification of fatty acid composition in plasma phospholipids, platelets, and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids. Eur J Clin Pharmacol. 2004;60:183–190.
   PubMed Web of Science ®Google Scholar
• Product review: fish oil and omega-3 fatty acid supplements review (including Krill, Algae, Calamari, Green-lipped Mussel Oil). Available from: Consumerlab.com.
   Google Scholar
• Yuen AW, Flugel D, Poepel A, et al. Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy. Epilepsy Behav. 2012;23:370–372.
   PubMed Web of Science ®Google Scholar
• Yuen AW, Sander JW, Fluegel D, et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav. 2005;7:253–258.
   PubMed Web of Science ®Google Scholar
• Bromfield E, Dworetzky B, Hurwitz S, et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav. 2008;12:187–190.
   PubMed Web of Science ®Google Scholar